Detailseite
Projekt Druckansicht

Struktur und Funktion thrombozytär exprimierter "junctional adhesion molecules" (JAMs) - Charakterisierung neuer heterophiler Interaktionen

Fachliche Zuordnung Kardiologie, Angiologie
Förderung Förderung von 2011 bis 2019
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 190538538
 

Zusammenfassung der Projektergebnisse

Junctional Adhesion Molecules (JAMs) belong to the immunoglobulin family of proteins, and they are expressed on a diverse range of cells, including endothelial cells, thrombocytes, and leukocytes. The JAM proteins regulate endothelial and epithelial „tight junctions“. The human homolog of JAM-A (hJAM-A), which is perhaps the best-known member of the family, serves as a ligand for the integrin LFA-1, and this interaction likely plays an important role in host inflammatory responses by mediating transmigration of leukocytes. Two hJAM-A homologs, hJAM-B and hJAM-C, were later identified, and shown to interact with integrins as well. JAMs can form homophilic and heterophilic interactions, and our project was aimed at establishing structures of JAM molecules and characterizing their homophilic and heterophilic interactions. Results obtained by the Langer group showed furthermore that the „extracellular matrix metalloproteinase inducer“ (EMMPRIN) is a new interaction partner for JAM-A, and we have therefore also undertaken efforts to characterize this interaction in more detail.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung